GSK ApS: Financial statements 2025
CVR: 43484621
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
GSK ApS (CVR 43484621) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 145,272 and a net result of DKK 105,272 compared with DKK 36,626 the year before. That is an increase of 89.6% compared with the year before. Equity in the 2025 report amounted to DKK 2,166,934. The solvency ratio was 100%.
- Gross Profit
- DKK 145,272
- Profit/Loss
- DKK 105,272
- Equity
- DKK 2,166,934
- Total Assets
- DKK 2,166,934
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 145 t. | 105 t. | 2.2 mio. | 0 |
| 2024 | 148 t. | 77 t. | 37 t. | 2.1 mio. | 0 |
Official annual report
How creditworthy is GSK ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout GSK ApS
GSK ApS is a Danish company of the type Anpartsselskab based in Gram, founded in 2022. The company is registered under the industry Køb og salg af egen fast ejendom. The management consists of Jacob Skole Olesen and Jørn Kudsk. The company is owned by JØRN KUDSK HOLDING ApS and Bak & Olesen ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 145,272 and a net result of DKK 105,272 compared with DKK 36,626 the year before. Equity in the 2025 report amounted to DKK 2,166,934.